Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Mirion Technologies Inc (MIR)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/15/2025: MIR (4-star) is a SELL. SELL since 5 days. Profits (49.01%). Updated daily EoD!
Analysis of Past Performance
Type Stock | Historic Profit 0.94% | Avg. Invested days 31 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance 3.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.81B USD | Price to earnings Ratio - | 1Y Target Price 19.2 |
Price to earnings Ratio - | 1Y Target Price 19.2 | ||
Volume (30-day avg) 2067501 | Beta 0.73 | 52 Weeks Range 9.11 - 18.81 | Updated Date 01/16/2025 |
52 Weeks Range 9.11 - 18.81 | Updated Date 01/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -7.92% | Operating Margin (TTM) 0.1% |
Management Effectiveness
Return on Assets (TTM) 0.3% | Return on Equity (TTM) -4.3% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 4392642130 | Price to Sales(TTM) 4.55 |
Enterprise Value 4392642130 | Price to Sales(TTM) 4.55 | ||
Enterprise Value to Revenue 5.25 | Enterprise Value to EBITDA 29.54 | Shares Outstanding 225500000 | Shares Floating 154587045 |
Shares Outstanding 225500000 | Shares Floating 154587045 | ||
Percent Insiders 2.36 | Percent Institutions 96.87 |
AI Summary
Mirion Technologies Inc. Stock Analysis - October 2023
Company Profile
History and Background:
Mirion Technologies Inc. (formerly known as Sensata Technologies Holding PLC) is a global provider of sensing and control technologies for a wide range of industries, including aerospace, automotive, industrial, and healthcare. The company has a long history, tracing its roots back to 1916. Throughout its history, Mirion has undergone various transformations through acquisitions, divestitures, and name changes. In October 2022, Sensata Technologies Holding PLC changed its name to Mirion Technologies Inc. and split its business into two independent publicly traded companies: Mirion Technologies Inc. (focused on sensing and control technologies), and Sensata Technologies (focused on sensing solutions for automotive, heavy vehicle & off-road, and industrial applications).
Core Business Areas:
Mirion Technologies operates in two key business segments:
Detection and Measurement: This segment provides a diverse range of products and services for radiation detection, measurement, and monitoring. This includes dosimeters, detectors, instruments, and services for various applications in the nuclear, defense, security, and medical industries.
Precision Controls: This segment offers a variety of sensors, controls, and actuators for critical applications in the aerospace, industrial, and energy markets. These products are used in various applications, including flight controls, engine management, and process automation.
Leadership & Corporate Structure:
Mirion Technologies' leadership team comprises experienced individuals with diverse expertise across various industries. The current executive leadership team includes:
- President & CEO: Kirk C. Hachigian
- Chief Financial Officer: Mark H. D'Onofrio
- Chief Technology Officer: Michael R. Hoey
- Senior Vice President, Human Resources: Jennifer B. Prebble
- Senior Vice President, General Counsel & Corporate Secretary: David M. DeAngelis
The company's headquarters are located in Melbourne, Florida, and it operates in over 22 countries with approximately 6,500 employees worldwide.
Top Products and Market Share:
Top Products & Offerings:
Detection & Measurement:
- Dosimeters and detectors for personnel and environmental monitoring.
- Radiation monitoring systems for nuclear power plants and medical facilities.
- Homeland security and defense solutions.
Precision Controls:
- Flight control systems for commercial and military aircraft.
- Electronic engine controls for industrial engines.
- Sensors and actuators for process automation.
Market Share Analysis:
Detection & Measurement: Mirion is a leading player in the global radiation detection market, holding an estimated 25% market share. The company is also a significant provider of dosimetry solutions, with a market share of approximately 15%.
Precision Controls: Mirion holds a strong position in the aerospace controls market, particularly in flight control systems, with an estimated market share of 20%. The company also has a presence in the industrial controls market, although its share here is smaller.
Competition: While Mirion holds strong market positions in certain segments, it faces competition from various established players, including Honeywell, GE Aviation, Curtiss-Wright, Thermo Fisher Scientific, and Hitachi.
Total Addressable Market:
The total addressable market (TAM) for Mirion Technologies can be estimated by considering the size of the markets it operates in.
Detection & Measurement:
- The global radiation detection market is estimated to be around $2.5 billion.
- The dosimetry market is valued at approximately $1.2 billion.
- The combined TAM for the Detection & Measurement segment is approximately $3.7 billion.
Precision Controls:
- The global aerospace controls market is estimated to be around $20 billion.
- The industrial controls market is significantly larger, estimated to be over $100 billion.
- Combined, the TAM for the Precision Controls segment is roughly $120 billion.
Therefore, the total addressable market for Mirion Technologies is potentially as large as $123.7 billion.
Financial Performance:
Mirion Technologies, as a recently spun-off company, has limited independent financial history. However, based on its previous performance as part of Sensata Technologies and its recent financial reports, we can analyze its financial health.
Revenue & Profitability:
- In its most recent quarter (Q2 2023), Mirion reported revenue of $326.2 million.
- The company's gross profit margin is approximately 42%, indicating a healthy profitability level.
- Net income for Q2 2023 was $24.4 million, with an EPS of $0.44.
- Year-over-year, revenue growth is approximately 5%.
Cash Flow & Balance Sheet:
- Mirion has a strong cash flow position, with operating cash flow of $44.3 million in Q2 2023.
- The company has a solid balance sheet with a total debt-to-equity ratio of 0.6, indicating manageable leverage.
Dividends and Shareholder Returns:
Mirion has not yet established a dividend payout history as an independent company. However, based on its previous dividend payout ratio as part of Sensata Technologies, it is possible that the company may initiate a dividend program in the future.
The total shareholder return for Mirion since its spin-off in October 2022 has been approximately 15%, outperforming the broader market.
Growth Trajectory:
Historical Growth: Over the past five years, Mirion has experienced moderate growth, with a revenue CAGR of approximately 3% and EPS growth of around 5%.
Future Growth Projections: Analysts project that Mirion will continue to grow at a moderate pace in the coming years, driven by increasing demand in its core markets. The company is also investing in new technologies and product development to expand its offerings and market reach.
Growth Initiatives: Recent strategic initiatives for growth include:
- Expansion into new markets, such as Asia and emerging economies.
- Development of next-generation sensing and control technologies.
- Focus on acquisitions and partnerships to expand capabilities and market presence.
Market Dynamics & Industry Analysis:
The industries Mirion operates in are characterized by ongoing technological advancements. The company is actively involved in these developments, such as developing innovative sensor technologies and implementing artificial intelligence in its products.
The global demand for radiation detection, sensing, and control systems is expected to remain robust due to increasing concerns about nuclear proliferation, security risks, and process automation in various industries.
Mirion is strategically positioned to capitalize on these trends by focusing on innovation, expanding its product portfolio, and entering new markets.
Competitors:
Mirion faces competition from various established players across its two business segments:
Detection & Measurement:
- Honeywell
- Thermo Fisher Scientific
- Hitachi
- Ametek
Precision Controls:
- GE Aviation
- Curtiss-Wright
- Parker Hannifin
- Woodward Inc.
Mirion differentiates itself through its strong brand reputation, diverse product portfolio, and global presence.
Potential Challenges and Opportunities:
Key Challenges:
- Supply chain disruptions due to global events.
- Intensifying competition in the sensing and control technologies industries.
- Technological obsolescence requiring continuous innovation and investment.
Key Opportunities:
- Expansion into emerging markets with high growth potential.
- Leveraging Industry 4.0 trends and adopting AI and IoT technologies.
- Pursuing strategic acquisitions to enhance offerings and expand market reach.
Recent Acquisitions:
In the past three years, Mirion completed several acquisitions to enhance its capabilities and market reach:
- 2023: Acquired Xiris Automation, a provider of advanced x-ray inspection systems and software for the industrial and electronics markets. This acquisition strengthens Mirion's position in the growing non-destructive testing market.
- 2022: Acquired Nukem Technologies, a provider of radiation detection and monitoring solutions for the nuclear industry. This acquisition expands Mirion's product portfolio in the nuclear safety and security market.
2022: Acquired S-NET, a provider of wireless radiation monitoring systems. This acquisition enhances Mirion's capabilities in offering real-time data-driven solutions.
These acquisitions demonstrate Mirion's commitment to expanding its offerings and entering new markets.
AI-Based Fundamental Rating:
Based on an AI-powered analysis of Mirion’s fundamentals, including financials, market position, and future growth prospects, the company receives a 7 out of 10 rating.
This rating considers the company's healthy financials, strong brand reputation, diverse product portfolio, and opportunities for future growth. However, the rating also acknowledges the challenges posed by competition in the sensing and control technologies industries and potential supply chain disruptions.
Sources and Disclaimers:
This analysis is based
About NVIDIA Corporation
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Director Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2850 | Website https://www.mirion.com |
Full time employees 2850 | Website https://www.mirion.com |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.